Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1214.61x is 50% below its 3-year average of -810.78x, around the middle of its 3-year range (-2036.59x–3.06x).
32.33% below its 12-month average of -917.88x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -574.59x.
INTEREST COVERAGE RATIO
-1214.61x
INTEREST COVERAGE RATIO AVG TTM
-917.88x
INTEREST COVERAGE RATIO AVG 3Y
-810.78x
INTEREST COVERAGE RATIO AVG 5Y
-810.78x
INTEREST COVERAGE RATIO AVG 10Y
-611.78x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-32.33%
CURRENT VS 3Y AVG
-49.81%
CURRENT VS 5Y AVG
-49.81%
CURRENT VS 10Y AVG
-98.54%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-18760.40%
vs the sector median at left
Fulgent Genetics, Inc.
Market Cap
$584.48M
Interest Coverage Ratio
-1214.61x
TTM Avg
-917.88x
3Y Avg
-810.78x
5Y Avg
-810.78x
Market Cap
$583.31M
Interest Coverage Ratio
-4.84x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$578.40M
Interest Coverage Ratio
-4.07x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$596.01M
Interest Coverage Ratio
-133.54x
TTM Avg
0.30x
3Y Avg
1.45x
5Y Avg
7.08x
Market Cap
$597.55M
Interest Coverage Ratio
3.63x
TTM Avg
3.22x
3Y Avg
13.13x
5Y Avg
10.34x
Market Cap
$571.13M
Interest Coverage Ratio
53.97x
TTM Avg
53.97x
3Y Avg
53.97x
5Y Avg
53.97x
Market Cap
$560.00M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$557.32M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fulgent Genetics, Inc. (FLGT) | $584.48M | -1214.61x | -917.88x | -810.78x | -810.78x |
| OrthoPediatrics Corp. (KIDS)vs › | $583.31M | -4.84x | N/A | N/A | N/A |
| Aquestive Therapeutics, Inc. (AQST)vs › | $578.40M | -4.07x | N/A | N/A | N/A |
| AngioDynamics, Inc. (ANGO)vs › | $596.01M | -133.54x | 0.30x | 1.45x | 7.08x |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $597.55M | 3.63x | 3.22x | 13.13x | 10.34x |
| CorMedix Inc. (CRMD)vs › | $571.13M | 53.97x | 53.97x | 53.97x | 53.97x |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| Climb Bio, Inc. (CLYM)vs › | $611.57M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $557.32M | N/A | N/A | N/A | N/A |
| SOPHiA GENETICS S.A. (SOPH)vs › | $619.15M | -15.57x | N/A | N/A | N/A |
Interest Coverage
-1214.6x
Debt/Equity
0.01
Current Ratio
6.34
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -574.59x |
| 2026-03-31 | -2036.59x |
| 2025-12-31 | -270.43x |
| 2025-09-30 | -548.21x |
| 2025-06-30 | -1159.59x |
| 2025-03-31 | -1413.93x |
| 2024-12-31 | -76.83x |
| 2024-09-30 | -1219.93x |
| 2023-09-30 | 3.06x |
| 2018-03-31 | -23.09x |
| 2017-12-31 | -21.34x |
| 2016-06-30 | 0.18x |
